Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.7.0 is now displayed on the page. Legacy study-record metadata and navigation text have been removed, representing an administrative cleanup of older content.SummaryDifference17%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe site revision label was updated to Revision: v3.6.6, indicating an underlying platform update. There are no changes to the displayed study details or related content.SummaryDifference0.1%

- Check46 days agoChange DetectedPage revision label updated from v3.6.4 to v3.6.5. This indicates a minor release of the page’s content or styling, without altering the main study information.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.6.4 now appears on the page, replacing the previous v3.6.3. This denotes a minor update to the ClinicalTrials.gov interface and does not modify the study content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3, indicating a minor update to the study record.SummaryDifference0.1%

- Check90 days agoChange DetectedPage revision label updated from v3.6.0 to v3.6.2, indicating a new revision of the page content. This appears to be a minor maintenance update and does not modify study data or user-facing information.SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.